157 completed, 30 unknown, 10 recruiting, 10 terminated. 219 Phase 3, 61 Phase 2.
Follow Motor Activity: new trials by email Literature Review of Motor Activity trials Research Report on Motor Activity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries | Phase 2 / Phase 3 | Not yet recruiting | VA Office of Research and Development | 300 | 2027-10-01 | 2026-08-04 |
| Partner4Exercise Study Peer matching, Quailfied Exercise Professional (QEP) Support - Cancer | Phase 2 / Phase 3 | Recruiting | McMaster University | 183 | 2026-09-01 | 2026-10-29 |
| The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED) Tirzepatide, Exercise - Obesity & Overweight | Phase 3 | Not yet recruiting | University of Virginia | 24 | 2026-08-01 | 2026-05-06 |
| Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome Cold Stress, Maximal Dynamic Exercise, Isometric Handgrip Exercise with Post-Exercise Muscle Ischemia - Down Syndrome, Autonomic Dysfunction | Phase 3 | Recruiting | University of Colorado, Denver | 200 | 2026-04-06 | 2026-10-13 |
| Modafinil and Exercise for Post Stroke Fatigue Modafinil 200mg, Placebo, Exercise - Stroke, Fatigue | Phase 3 | Not yet recruiting | University Health Network, Toronto | 212 | 2025-09-01 | 2025-06-10 |
| PAH Exercise Study Home exercise program - Pulmonary Arterial Hypertension (PAH), Exercise Therapy | Phase 3 | Recruiting | University of Washington | 10 | 2025-04-15 | 2025-04-23 |
| Randomized Controlled Physical Activity App Intervention for Black Women PA4Health app physical activity intervention, Wellness Text Messaging Program - Physical Activity | Phase 3 | Active not recruiting | Stony Brook University | 50 | 2025-03-09 | 2025-09-03 |
| Immunoscore As Decision Guidance for Adjuvant Chemotherapy in Colon Cancer Capecitabine, Oxaliplatin, Fluorouracil - Colon Cancer Stage III | Phase 3 | Withdrawn | Johannes Laengle, MD, PhD | 2024-12-01 | 2024-09-20 | |
| The MUSE Study for Menopausal Arthralgia Menopausal hormone therapy, Exercise training, Menopausal hormone therapy + exercise training - Arthralgia, Menopause | Phase 2 / Phase 3 | Recruiting | National University Hospital, Singapore | 100 | 2024-08-01 | 2024-07-31 |
| Wereables for Upper Limb Functionality in Hemiparesis WeFun-wearable activated, WeFun-wearable desactivated - Unilateral Cerebral Palsy | Phase 2 / Phase 3 | Recruiting | Universidade da Coruña | 40 | 2024-06-07 | 2025-03-12 |
| 18F-FLUC PET/MR in Patients With Brain Mets F-Fluciclovine radiotracer - Brain Metastasis, Radiation Therapy | Phase 3 | Recruiting | University of Wisconsin, Madison | 30 | 2024-01-10 | 2026-06-22 |
| CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease CoQ10, Placebo, HB-HIIT - End Stage Renal Disease | Phase 3 | Recruiting | Vanderbilt University Medical Center | 156 | 2023-06-01 | 2026-01-02 |
| Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer Tislelizumab in Combination with Bacillus Calmette-Guérin - Urinary Bladder Neoplasms, BCG Vaccine | Phase 3 | Recruiting | Fujian Medical University Union Hospital | 76 | 2023-06-01 | 2024-06-04 |
| Investigate the Relationship Between Exercise Training and Recovery Ratio to Improve Physical Performance and Health Status A regular training volume, A lower exercise volume group, A longer rest group - Exercise, Recovery | Phase 3 | Unknown | Tel Aviv University | 200 | 2023-06-01 | 2024-02-23 |
| Effectiveness of Topical Menthol as A Cooling Method During Exercise in A Recreational Runner Population Light blue gel with the trademark Counterpain COOL® (License Number: POM QD. 111 709 501) containing the active substance Menthol 4%., Placebo - Heat Stress, Athletic Performance | Phase 2 / Phase 3 | Completed | Taisho Pharmaceutical Indonesia | 37 | 2023-05-30 | 2026-03-19 |
| A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities Tirzepatide, Semaglutide - Obesity, Overweight | Phase 3 | Completed | Eli Lilly and Company | 751 | 2023-04-21 | 2025-11-26 |
| The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease Methylprednisolone + ASTED, Methylprednisolone +Placebo - Thyroid Eye Disease | Phase 2 / Phase 3 | Withdrawn | Iran University of Medical Sciences | 2022-09-01 | 2022-01-10 | |
| Blood Flow and Blood Pressure Investigation in Down Syndrome Exercise - Down Syndrome | Phase 3 | Completed | University of Illinois at Chicago | 48 | 2022-09-01 | 2024-04-18 |
| Can We Achieve 'high-quality' Weight Loss Through Supplementation and Exercise? the TRIM MUSCLE Study Muscle5 and TRIM7, Mixed exercise - Overweight, Obesity | Phase 3 | Completed | Exerkine Corporation | 51 | 2022-08-15 | 2025-01-08 |
| A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol Inhaled isoflurane administered by Sedaconda ACD-S, Intravenous infusion of propofol - Post-Intensive Care Syndrome, Sedation | Phase 3 | Active not recruiting | Sedana Medical | 312 | 2022-04-22 | 2025-02-05 |
Showing 20 of 219. Sign in to see all of them.
Obesity (31) · Breast Neoplasms (12) · Overweight (10) · Diabetes Mellitus (9) · Neoplasms (9) · Fatigue (8) · Osteoarthritis (8) · Weight Loss (8) · Diabetes Mellitus, Type 2 (7) · Hypertension (7) · Pain (7) · Pulmonary Disease, Chronic Obstructive (7) · Cardiovascular Diseases (6) · Depression (6)
Behavior (217) · Pathological Conditions, Signs and Symptoms (83) · Signs and Symptoms (65) · Nutritional and Metabolic Diseases (53) · Overnutrition (33) · Nutrition Disorders (32) · Body Weight (31) · Neoplasms (30) · Neoplasms by Site (30) · Metabolic Diseases (29) · Cardiovascular Diseases (28) · Musculoskeletal Diseases (27) · Nervous System Diseases (27) · Pathologic Processes (25) · Overweight (23)
Exercise (54) · Resistance Training (8) · Exercise Therapy (6) · Diet (4) · Dietary Supplements (4) · Educational Status (4) · Health (4) · Metformin (4) · Nutrition Assessment (4) · Testosterone (3) · Tirzepatide (3) · Vitamin D (3) · Absorptiometry, Photon (2) · Cardiac Rehabilitation (2) · Counseling (2)
Charite University, Berlin, Germany (9) · University of Erlangen-Nürnberg Medical School (6) · The Miriam Hospital (5) · Washington University School of Medicine (5) · Centers for Disease Control and Prevention (4) · University of Southern Denmark (4) · Basque Health Service (3) · Duke University (3) · Federal University of São Paulo (3) · Ottawa Hospital Research Institute (3) · University of Alberta (3) · University of Colorado, Denver (3) · University of Pennsylvania (3) · University of Saskatchewan (3) · VA Office of Research and Development (3)
United States (83) · Germany (26) · Canada (20) · Denmark (13) · Brazil (12) · Spain (9) · Ireland (6) · United Kingdom (6) · France (5) · Netherlands (5) · Australia (4) · China (3) · Finland (3) · Italy (3) · Norway (3)
Fernando Dimeo, MD (6) · Jennifer M Hootman, PhD (4) · Dennis T Villareal, MD (3) · Tara Cusack, PhD (3) · Cheryl L Albright, PhD, MPH (2) · Ellen Binder, MD (2) · James A. Blumenthal, PhD (2) · Kerry S Courneya, PhD (2) · Mitesh Patel, MD, MBA, MS (2) · Philip D Chilibeck, PhD (2) · Punam Pahwa, PhD (2) · Susan Whiting, PhD (2) · Willi A Kalender, PhD (2)
PMID 25706090, PMID 11832527, PMID 15963313, PMID 16358136, PMID 16487841, PMID 16636211, PMID 16855264, PMID 16990155, PMID 17133529, PMID 17557948, PMID 17761004, PMID 17767724, PMID 17846259, PMID 17898990, PMID 17996052, PMID 18029233, PMID 18060837, PMID 18163409, PMID 18544707, PMID 18570643, PMID 18582371, PMID 18716482, PMID 18784409, PMID 18839134, PMID 18840807, PMID 19061704, PMID 19131464, PMID 19171717, PMID 19364999, PMID 19365563, PMID 19433757, PMID 19433812, PMID 19643946, PMID 19734776, PMID 19837534, PMID 19900934, PMID 20056720, PMID 20100317, PMID 20101013, PMID 20171529, PMID 20347286, PMID 20530557, PMID 20565161, PMID 20624316, PMID 20682687, PMID 20723221, PMID 20798023, PMID 20837834, PMID 20861750, PMID 20864755
2016 (2), R01AG025501 (2), 2015 (1), 2023 (1), I01RX001507 (1), K23MD014164 (1), P30GM127211 (1), P50CA098258 (1), P50GM060338 (1), R00HD060762 (1), R01AG014777 (1), R01AG034581 (1), R01AG053952 (1), R01AG054454 (1), R01AG060050 (1)